A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases

By Howell A.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite

Fulvestrant versus anastrazole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 137-138

Informa Healthcare

Access to resources Recommend Favorite

Anastrozole (Arimidex(TM)) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

By Nabholtz J.M.   Bonneterre J.   Buzdar A.   Robertson J.F.R.   Thurlimann B.   for the Arimidex Writing Committee on behalf of the Investigators  

European Journal of Cancer, Vol. 39, Iss. 12, 2003-08 ,pp. : 1684-1689

Elsevier

Access to resources Recommend Favorite

A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer

By Carlson Robert  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1049-1056

Springer Publishing Company

Access to resources Recommend Favorite

Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)

By Pritchard Kathleen  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 453-461

Springer Publishing Company

Access to resources Recommend Favorite